Cargando…
Detection of SARS-CoV-2 Antibodies in Immunoglobulin Products
BACKGROUND: For patients with primary antibody deficiency, the first line of therapy is replacement with immunoglobulin (Ig) products. Prior to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, Ig products did not contain antibodies with specificity for this virus, and there...
Autores principales: | Cousins, Kimberley, Sano, Kaori, Lam, Brandon, Röltgen, Katharina, Bhavsar, Disha, Singh, Gagandeep, McRae, Oliver, Jeong, Stephanie, Aboelregal, Nouran, Ho, Hsi-en, Boyd, Scott, Krammer, Florian, Cunningham-Rundles, Charlotte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176888/ https://www.ncbi.nlm.nih.gov/pubmed/37182564 http://dx.doi.org/10.1016/j.jaip.2023.05.005 |
Ejemplares similares
-
A041 DETECTION OF SARS-COV-2 ANTIBODIES IN IMMUNOGLOBULIN PRODUCTS
por: Cousins, K., et al.
Publicado: (2021) -
SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals
por: Sano, Kaori, et al.
Publicado: (2022) -
Non-infectious Complications of Common Variable Immunodeficiency: Updated Clinical Spectrum, Sequelae, and Insights to Pathogenesis
por: Ho, Hsi-en, et al.
Publicado: (2020) -
Seeking Relevant Biomarkers in Common Variable Immunodeficiency
por: Ho, Hsi-en, et al.
Publicado: (2022) -
Prioritization of Evidence-Based Indications for Intravenous Immunoglobulin
por: Orange, Jordan S., et al.
Publicado: (2013)